Giardiasis as a cause of hypokalemic myopathy in congenital immunodeficiency

International Journal of Clinical and Laboratory Research

Volumn 26, Issue 2, 1996, Pages 132-135

  Genovese, A ^a   Spadaro, G ^a   Santoro, L ^b   Gasparo Rippa, P ^c   Onorati, A M ^a   Marone, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Stazione Climatica Bianchi   (Italy)

Author keywords

Common variable hypogammaglobulinemia; Giardia lamblia infection; Hypokalemic myopathy; Pathological findings

Indexed keywords

GIARDIA INTESTINALIS;

EID: 0029766163     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02592356     Document Type: Article

References (27)

1. Dickson BA, Franks RC. Aldosterone-producing adenoma presenting with hypokalemic myopathy Case report and review. Clin Pediatr (Phila) 1988; 27: 344.
2. Ishikawa S, Saito T, Okada K, Atsumi T, Kuzuya T, Hypokalemic myopathy associated with primary aldosteronism and glycyrrhizin-induced pseudoaldosteronism. Endocrinol Jpn 1985; 32: 793.
3. Shintani S, Murase H, Tsukagoshi H, Shiigai T. Glycyrrhizin (licorice)-induced hypokalemic myopathy. Report of 2 cases and review of the literature. Eur Neurol 1992; 32: 44.
4. Hayashi K, Hayashi R, Maruyama K, Yanagisawa N. Histopathologic and MRI findings in hypokalemic myopathy induced by glycyrrhizm. Acta Neurol Scand 1995; 92: 127.
5. Cosentino F, Mantelli I. Cosentino F. Hypokalemic myopathy, high levels of muscle enzymes and myocardial ischemia secondary to the topical administration of 9-alpha-fluoro-prednisolone. Clin Ter 1986; 116: 509.
6. Molins A, Alvarez-Sabin J, Montalban J, Molero J, Alegre J, Codina A. Hypopotassemic myopathy caused by topical administration of 9-alpha-fluoroprednisolone.Neurologiga 1987; 2: 244.
7. Shintani S, Shiigai T, Tsukagoshi H. Marked hypokalemic rhabdomyolysis with myoalobinuria due to diuretic treatment. Eur Neurol 1991; 31: 396.
8. Rizzi R, Micoli A, Giaculli G, Lella A, Mariella F. Hypokalemic myopathy during prolonged anti-hypertensive therapy with indapamide. Clin Ter 1985; 114: 233.
9. Williams SG, Davison AG, Glynn MJ. Hypokalaemic rhabdomyolysis: an unusual presentation of coeliac disease. Eur J Gastroenterol Hepatol 1995; 7: 183.
10. Murai K, Tsuruta K, Yamamura Y, Kuribayashi T, Kurihara T, Matsukura S. Hypokalemic myopathy associated with radiation enteropathy. Eur Neurol 1986; 25: 444.
11. Orman RA, Lewis JB Jr. Flaccid quadriparesis associated with Yerisinia enterocolitis-induced hypokalemia. Arch Intern Med 1989; 149: 1193.
12. Hill DR. Giardia lamblia. In: Mandell GL, Douglas RG Jr. Bennett JE, eds. Principles and practice of infectious diseases, 3rd edn. New York: Churchill Livingstone; 1990; 2110-2115.
13. Cervello A, Alfaro A, Chumillas MJ. Hypokalemic myopathy induced by Giardia lamblia. N Engl J Med 1993; 329: 210.
14. Dubowitz V. Muscle biopsy. A practical approach, 2nd edn. London: Bailliere Tindall. 1985.
15. Engel AG. Periodic paralysis. In: Engel AG, Banker BQ, eds. Myology. basic and clinical. New York: McGraw-Hill; 1986; 1843-1870
16. Engel AG. Hypokalemic and hyperkalemic periodic paralyses. In: Goldenson E. Apel S. eds. Scientific approaches to clinical neurology, vol 2. Philadelphia: Lea and Febiger; 1977; 1742-1765.
17. McArdle B. Metabolic myopathies. Am J Med 1963; 35: 661.
18. Klein R, Egan T, Usher P. Changes in sodium, potassium and water in hyperkalemic familial periodic paralysis. Metabolism 1960; 9: 1005.
19. Samaha FJ. Hyperkalemic periodic paralysis. Arch Neurol 1965; 12: 145.
20. Resnick JS, Engel WK, Grigss RC, Stam AC. Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med 1968; 278: 582.
21. Atsumi T, Ishikawa S, Miyatake T, Yoshida M. Myopathy and primary aldosteronism: electron microscopic study. Neurology 1979; 29: 1348
22. Bautista J, Gil-Neciga E, Gil-Peralta A. Hypokalemic periodic paralysis in primary hyperaldosteronism: subchnical myopathy with atrophy of the type 2 A muscle fibers. Eur Neurol 1979; 18: 415.
23. Addiss DG, Lengerich EJ. Hypokalemic myopathy induced by Giardia lamblia. N Engl J Med 1994; 330: 66.
24. Warhurst DC, Smith H. Getting to the guts of the problem. Parasitol Today 1992; 8: 292.
25. Health Care Financing Administration Medicare provider analysis and review file (machine-readable data files). Baltimore: Department of Health and Human Services. 1984-1990.
26. Mineral and electrolyte disorders. In: Layzer RB, ed. Neuromuscular manifestations of systemic disease. Contemporary neurology series, vol 25. Philadelphia: Davis; 1985; 47-77.
27. Harvey AM, Johns RJ, McKusick VA, Owens AH Jr, Ross RS. eds. The principles and practice of medicine. 22nd edn. Norwalk, Connecticut: Appleton and Lange: 1988: 701.